Results 11 to 20 of about 110,519 (362)

Cyclooxygenase enzyme and PGE2 expression in patients with functional and non-functional pituitary adenomas

open access: yesBMC Endocrine Disorders, 2020
Background Pituitary adenomas as multifactorial intracranial neoplasms impose a massive burden of morbidity on patients and characterizing the molecular mechanism underlying their pathogenesis has received considerable attention.
Nasrin Akbari   +9 more
doaj   +1 more source

Coexistence of Pituitary Adenoma and Primary Pituitary Lymphoma: A Case Report and Review of the Literature

open access: yesFrontiers in Surgery, 2022
In the pituitary sella, the coexistence of pituitary adenoma and primary pituitary lymphoma is exceedingly rare. Thus far, only six cases have been reported. Here, we present the seventh case of coexisting pituitary adenoma and primary pituitary lymphoma,
Shangjun Ren   +6 more
doaj   +1 more source

Aggressive Pituitary Tumors [PDF]

open access: yesNeuroendocrinology, 2015
Pituitary adenomas are common intracranial tumors that are mainly considered as benign. Rarely, these tumors can exhibit an aggressive behavior, characterized by gross invasion of the surrounding tissues, resistance to conventional treatment leading to early and frequent recurrences.
Chatzellis, E.   +3 more
openaire   +3 more sources

Evaluation and Current Clinical Progress of Invasiveness in Postoperative Residual Regrowth and Recurrence of Pituitary Adenoma

open access: yesZhongliu Fangzhi Yanjiu, 2022
Pituitary adenoma is one common type of intracranial tumors, accounting for about 10% of intracranial tumors. Although pituitary adenomas are benign tumors, the complete resection and recurrence prevention remain challengeable due to aggressive growth of
LEI Ting   +5 more
doaj   +1 more source

Increased expression of programmed death ligand 1 (PD-L1) in human pituitary tumors [PDF]

open access: yes, 2016
PURPOSE: Subsets of pituitary tumors exhibit an aggressive clinical courses and recur despite surgery, radiation, and chemotherapy. Because modulation of the immune response through inhibition of T-cell checkpoints has led to durable clinical responses ...
Agar, Nathalie Y. R.   +13 more
core   +3 more sources

The 2017 WHO classification and International Classification of Disease coding analysis of non⁃neuroendocrine tumors in the pituitary gland

open access: yesChinese Journal of Contemporary Neurology and Neurosurgery, 2022
The fourth edition of the latest classification principles for endocrine tumors was published by the World Health Organization (WHO) in 2017. The latest tumor classification and new pathological classification of each pituitary gland tumor were given in ...
GUAN Hong   +4 more
doaj   +1 more source

Corticotropinoma as a Component of Carney Complex. [PDF]

open access: yes, 2017
Known germline gene abnormalities cause one-fifth of the pituitary adenomas in children and adolescents, but, in contrast with other pituitary tumor types, the genetic causes of corticotropinomas are largely unknown.
Chittiboina, Prashant   +11 more
core   +2 more sources

Pituitary tumors and the risk of other malignancies: is the relationship coincidental or causal?

open access: yesEndocrine Oncology, 2023
Pituitary adenomas are benign neoplasms of the pituitary. The most prevalent are prolactinomas and non-functioning pituitary adenomas, followed by growth hormone-and ACTH-secreting adenomas.
Sandra Pekic   +2 more
doaj   +1 more source

The role of stereotactic radiosurgery in the multimodal management of growth hormone–secreting pituitary adenomas [PDF]

open access: yes, 2010
Growth hormone (GH)–secreting pituitary adenomas represent a common source of GH excess in patients with acromegaly. Whereas surgical extirpation of the culprit lesion is considered first-line treatment, as many as 19% of patients develop recurrent ...
Liu, Charles Y.   +2 more
core   +1 more source

Pituitary Tumors [PDF]

open access: yesEndocrinology and Metabolism Clinics of North America, 2015
Pituitary tumors are commonly encountered intracranial neoplasms that are invariably benign. Classic oncogene mutations are not encountered in these tumors, and disrupted cell cycle control and growth factor signaling likely contribute to pathogenesis and natural history.
openaire   +2 more sources

Home - About - Disclaimer - Privacy